[Improved pharmacokinetics. Fast tryptan with sustained response].
D000284:Administration, Oral; D018849:Controlled Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D023303:Oxazolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010880:Piperidines / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010919:Placebos; D011759:Pyrrolidines / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D018170:Sumatriptan / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors; D014363:Tryptamines
D003692:Delayed-Action Preparations; D007211:Indoles; D023303:Oxazolidinones; D010880:Piperidines; D010919:Placebos; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; C089750:zolmitriptan; D018170:Sumatriptan; C106783:naratriptan